Clearside Biomedical to Participate in Upcoming Investor Events in November and December 2021
November 11 2021 - 6:05AM
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical
company revolutionizing the delivery of therapies to the back of
the eye through the suprachoroidal space (SCS®), announced today
that it will participate in the following investor events, which
will each be held in a virtual meeting format:
Stifel 2021 Virtual Healthcare
ConferenceWednesday, November 17, 2021 at 8:00 am
ET
Piper Sandler 33rd Annual Virtual
Healthcare Conference Monday, November 29 – Thursday,
December 2, 2021 Recorded Presentation will be available: Monday,
November 22, 2021, at 10:00 a.m. ET
BTIG Ophthalmology DayTuesday,
November 30, 2021
UBS Ophthalmology Day Monday,
December 6, 2021
A link to the live and archived webcasts may be
accessed on the Clearside website under the Investors section:
Events and Presentations.
About Clearside Biomedical
Clearside Biomedical, Inc. is a
biopharmaceutical company revolutionizing the delivery of therapies
to the back of the eye through the suprachoroidal space (SCS®).
Clearside’s SCS injection platform, utilizing the Company’s
proprietary SCS Microinjector®, enables an in-office, repeatable,
non-surgical procedure for the targeted and compartmentalized
delivery of a wide variety of therapies to the macula, retina or
choroid to potentially preserve and improve vision in patients with
sight-threatening eye diseases. Clearside is developing its own
pipeline of small molecule product candidates for administration
via its SCS Microinjector and strategically partners its SCS
injection platform with companies utilizing other ophthalmic
therapeutic innovations. Clearside’s first product, XIPERE™
(triamcinolone acetonide injectable suspension) for suprachoroidal
use, was approved by the U.S. Food and Drug Administration in
October 2021. For more information, please visit
www.clearsidebio.com.
Investor and Media Contacts:Jenny Kobin Remy
Bernarda ir@clearsidebio.com(678) 430-8206
Source: Clearside Biomedical, Inc.
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clearside Biomedical (NASDAQ:CLSD)
Historical Stock Chart
From Sep 2023 to Sep 2024